Please Wait.....
Report
Enteral Feeding Formulas Market by Product (Polymeric, Elemental, Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) - Global Forecast to 2027
Market Report I 2022-08-10 I 224 Pages I MarketsandMarkets
The global enteral feeding formula market is projected to reach USD 8.2 billion by 2027 from USD 5.2 billion in 2022, growing at a CAGR of 9.5% during the forecast period. Over the years, enteral feeding formula have received importance in the healthcare industry, due to their various advantages over the traditional methods of nutrition administration, such as parenteral nutrition. Apart from being cost-intensive, parenteral nutrition is also associated with complications such as infections. Thus, the demand for enteral feeding formula is growing globally. Factors such as rising healthcare costs; a surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period. Moreover, the shift from parenteral nutrition to enteral nutrition and growing adoption of and demand for enteral feeding formula in long term care facilities are also expected to drive the market in the coming years. In addition, insufficient or lack of reimbursements in some developing and underdeveloped countries and a dearth of trained physicians across the globe pose significant challenges for the growth of this market.
Based on product, the standard formula segment holds the largest share during the forecast period.
Based on product, the enteral feeding formulas market is segmented into standard (polymeric), peptide-based (elemental/semi-elemental), disease-specific, and other formulas. In 2021 standard formulas held the largest share, followed by disease-specific formulas. Standard formulas are easily available and widely used to fulfill daily requirements. The rising prevalence of target ailments thus plays a greater role in driving demand for standard formulas.
Based on application, the oncology segment holds the highest growth during the forecast period.
In 2021, the oncology segment accounted for the largest share of the enteral feeding formula market, followed by gastrointestinal diseases, neurological disorders, diabetes, and other applications. Increasing burden of cancer, the shift from hospitals to ambulatory care settings and the rising adoption of enteral feeding as an efficient alternative to parenteral nutrition among cancer patients are likely to fuel the demand for enteral feeding formulas in oncological applications.
Based on age group, the adult segment holds the largest share during the forecast period
Based on age group, the enteral feeding formula market is segmented into adult patients (18 years and over) and pediatric patients (neonates under 1 month, infants between 1 month and 2 years of age, children between 2 and 12 years, and adolescents between 12 and 16 years). In 2021, there has been a increase in adult patients accounted for a larger market share. This can be attributed to the growing incidence of cancer in adult patients, As most cancer patients suffer from malnutrition, an increase in cancer cases is expected to increase the demand for effective enteral nutrition. Also increase in chronic diseases are resulting in malnutrition and the rapid increase in the geriatric population are positively impacting market.
Based on end user, the long term care facilities holds the higher market share during the forecast period.
In 2021, Long term care facilities have a higher CAGR. Patients suffering from chronic diseases and disorders are advised long-term care or home care, depending upon the severity of the disease/disorder. Due to the increasing pressure on hospitals to curtail the soaring healthcare costs and the COVID-19 outbreak, there has been a shift from extended hospital treatment toward treatment at home. Studies reveal that home enteral nutrition (HEN) is significantly cheaper than home parenteral nutrition in the US. Growing awareness of therapeutic nutrition has contributed to the use of enteral nutrition products by patients at home.Thus end user segment registered higher market share.
APAC is expected to grow at the highest growth rate in 2021
During the forecast period, the Asia Pacific is estimated to be the fastest-growing regional market for enteral feeding formula. Several factors, such as the rising geriatric population, increased awareness of and accessibility to advanced healthcare facilities, rising healthcare spending, the growing focus of key market players on emerging APAC countries, and rapid improvements in the health insurance sector are driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Company: Tier 1- 60%, Tier 2 - 30%, and Tier 3- 10%
- By Designation: C-Level- 30%%, Director level - 50%, and Others - 20%
- By Region: North America -45%, Europe -15%, Asia-Pacific -25%, Latin America - 10%, and Middle East and Africa - 5%
Key players in the enteral feeding formula market
Prominent players in this market include Abbott (US), Nestle S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi (Germany), B. Braun Melsungen AG (Germany), Otsuka Holding Co. Ltd. (Japan), Nutritional Medicinals, LLC (US), Kate Farms (US), Medtrition Inc. (US), Victus, Inc. (US), Global Health Products, Inc. (US), Meiji Holdings Co., Ltd. (Japan), Reckitt Benckiser Group PLC. (UK), Hormel Foods Corporation (US), DermaRite Industries, LLC. (US), Medline Industries, LP. (US), Real Food Blends (US), and Ajinomoto Cambrooke, Inc. (US).
Research Coverage:
The report analyzes the enteral feeding formula market and aims at estimating the market size and future growth potential of this market based on various segments such as product, stage, application, end user and region. The report also includes a product portfolio matrix of various enteral feeding products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global enteral feeding formula market. The report analyzes this market by product, stage, application, end user, and region
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global enteral feeding formula market
- Market Development: Comprehensive information on the lucrative emerging markets by product type, age group, application, end user, and region
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global enteral feeding formula market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global enteral feeding formula market.
1 INTRODUCTION 33
1.1 OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 STUDY SCOPE 34
FIGURE 1 ENTERAL FEEDING FORMULAS MARKET 34
1.4 YEARS CONSIDERED 34
1.5 CURRENCY CONSIDERED 35
1.6 LIMITATIONS 35
1.7 STAKEHOLDERS 35
1.8 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 2 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
FIGURE 3 ENTERAL FEEDING FORMULAS MARKET: BREAKDOWN OF PRIMARIES 39
2.2 MARKET SIZE ESTIMATION 40
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF ENTERAL FEEDING FORMULAS 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2021 41
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2021 41
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 43
FIGURE 7 ENTERAL FEEDING FORMULAS MARKET: CAGR PROJECTIONS, 2022-2027 43
FIGURE 8 ENTERAL FEEDING FORMULAS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 46
FIGURE 10 DATA TRIANGULATION METHODOLOGY 46
2.5 INSIGHTS FROM PRIMARIES 47
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS 47
2.6 RESEARCH ASSUMPTIONS 47
2.7 RISK ANALYSIS 48
?
3 EXECUTIVE SUMMARY 49
FIGURE 12 ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 49
FIGURE 13 ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2022 VS. 2027 (USD MILLION) 50
FIGURE 14 ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 50
FIGURE 15 ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 51
FIGURE 16 GEOGRAPHIC ANALYSIS: ENTERAL FEEDING FORMULAS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 ENTERAL FEEDING FORMULAS MARKET OVERVIEW 53
FIGURE 17 INCREASING PREVALENCE OF CHRONIC DISEASES AND SHIFT FROM PARENTERAL NUTRITION TO ENTERAL NUTRITION TO DRIVE MARKET GROWTH 53
4.2 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY TYPE (2022) 54
FIGURE 18 STANDARD FORMULAS TO DOMINATE APAC ENTERAL FEEDING FORMULAS MARKET IN 2022 54
4.3 ENTERAL FEEDING FORMULAS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 19 MARKET IN CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 55
4.4 ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 56
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE ENTERAL FEEDING FORMULAS MARKET TILL 2027 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 21 ENTERAL FEEDING FORMULAS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Benefits and cost-effectiveness of enteral over parenteral nutrition 58
5.2.1.2 Rising preterm births fueling demand for enteral feeding formulas 58
FIGURE 22 US: TOTAL NUMBER OF PRETERM BIRTHS, 2010-2020 59
5.2.1.3 Growing demand for enteral feeding in home care 59
5.2.1.4 Rapid growth in geriatric population and disease prevalence 60
FIGURE 23 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 60
FIGURE 24 GLOBAL CANCER INCIDENCE, 2015-2040 61
FIGURE 25 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995-2030 (MILLION INDIVIDUALS) 62
TABLE 1 DRIVERS: IMPACT ANALYSIS 62
5.2.2 RESTRAINTS 62
5.2.2.1 Complications associated with enteral feeding 62
TABLE 2 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING 63
5.2.2.2 Lack of patient awareness 63
TABLE 3 RESTRAINTS: IMPACT ANALYSIS 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Emergence of new products and innovation 64
5.2.3.2 High growth opportunities in emerging countries 64
TABLE 4 OPPORTUNITIES: IMPACT ANALYSIS 65
5.2.4 CHALLENGES 65
5.2.4.1 Insufficient reimbursements for enteral nutrition 65
5.2.4.2 Dearth of skilled professionals 65
TABLE 5 CHALLENGES: IMPACT ANALYSIS 66
5.3 PORTER'S FIVE FORCES ANALYSIS 66
TABLE 6 PORTER'S FIVE FORCES ANALYSIS 66
5.3.1 THREAT FROM NEW ENTRANTS 67
5.3.2 THREAT FROM SUBSTITUTES 67
5.3.3 BARGAINING POWER OF SUPPLIERS 67
5.3.4 BARGAINING POWER OF BUYERS 67
5.3.5 COMPETITIVE RIVALRY 68
5.4 REGULATORY SCENARIO 68
5.4.1 REGULATORY ANALYSIS 68
5.5 VALUE CHAIN ANALYSIS 69
FIGURE 26 ENTERAL FEEDING FORMULAS MARKET: VALUE CHAIN ANALYSIS 70
5.6 SUPPLY CHAIN ANALYSIS 70
FIGURE 27 ENTERAL FEEDING FORMULAS MARKET: SUPPLY CHAIN ANALYSIS 71
5.7 ECOSYSTEM MARKET MAP 72
FIGURE 28 ENTERAL FEEDING FORMULAS MARKET: ECOSYSTEM MARKET MAP 72
5.8 PRICING ANALYSIS 73
TABLE 7 AVERAGE PRICE OF ENTERAL FEEDING FORMULAS, IN USD (2021) 73
TABLE 8 AVERAGE SELLING PRICES OF ENTERAL FEEDING FORMULAS,
2017-2021 (USD) 73
5.9 PATENT ANALYSIS 74
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERAL FEEDING FORMULA PATENTS (JANUARY 2011-OCTOBER 2021) 74
TABLE 9 INDICATIVE LIST OF PATENTS IN ENTERAL FEEDING FORMULAS MARKET 75
5.10 KEY CONFERENCES AND EVENTS IN 2022-2023 76
TABLE 10 ENTERAL FEEDING FORMULAS MARKET: LIST OF CONFERENCES AND EVENTS 76
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 77
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ENTERAL FEEDING PRODUCTS 77
5.12 KEY BUYING CRITERIA FOR END USERS 77
FIGURE 31 ENTERAL FEEDING FORMULAS MARKET: BUYING CRITERIA OF END USERS 77
?
6 ENTERAL FEEDING FORMULAS MARKET, BY STAGE 78
6.1 INTRODUCTION 79
TABLE 11 ENTERAL FEEDING FORMULAS MARKET, BY STAGE,
2020-2027 (USD MILLION) 79
6.2 ADULTS 79
6.2.1 INCREASED PREVALENCE OF CHRONIC DISEASES AND NEUROLOGICAL DISORDERS IN ADULT PATIENTS TO INCREASE MARKET SHARE 79
TABLE 12 ENTERAL FEEDING FORMULAS MARKET FOR ADULTS, BY REGION, 2020-2027 (USD MILLION) 80
TABLE 13 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR ADULTS, BY COUNTRY, 2020-2027 (USD MILLION) 81
TABLE 14 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR ADULTS, BY COUNTRY, 2020-2027 (USD MILLION) 81
TABLE 15 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR ADULTS, BY COUNTRY, 2020-2027 (USD MILLION) 81
6.3 PEDIATRICS 82
6.3.1 GROWING DISEASE PREVALENCE IN PEDIATRIC PATIENTS DRIVING MARKET GROWTH 82
TABLE 16 ENTERAL FEEDING FORMULAS MARKET FOR PEDIATRICS, BY REGION, 2020-2027 (USD MILLION) 83
TABLE 17 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR PEDIATRICS, BY COUNTRY, 2020-2027 (USD MILLION) 83
TABLE 18 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR PEDIATRICS, BY COUNTRY, 2020-2027 (USD MILLION) 84
TABLE 19 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR PEDIATRICS, BY COUNTRY, 2020-2027 (USD MILLION) 84
7 ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT 85
7.1 INTRODUCTION 86
TABLE 20 ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 86
7.2 STANDARD FORMULAS 86
7.2.1 EASE OF ACCESSIBILITY AND COST-EFFECTIVENESS WILL INCREASE MARKET GROWTH 86
TABLE 21 STANDARD ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 87
TABLE 22 NORTH AMERICA: STANDARD ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 87
TABLE 23 EUROPE: STANDARD ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 88
TABLE 24 ASIA PACIFIC: STANDARD ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 88
7.3 DISEASE-SPECIFIC FORMULAS 88
TABLE 25 DISEASE-SPECIFIC ENTERAL FEEDING FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 89
TABLE 26 DISEASE-SPECIFIC ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 89
TABLE 27 NORTH AMERICA: DISEASE-SPECIFIC ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 89
TABLE 28 EUROPE: DISEASE-SPECIFIC ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 90
TABLE 29 ASIA PACIFIC: DISEASE-SPECIFIC ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 90
7.3.1 DIABETIC FORMULAS 90
7.3.1.1 Increased incidence of diabetes patients driving market growth 90
TABLE 30 DIABETIC FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 91
TABLE 31 NORTH AMERICA: DIABETIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 91
TABLE 32 EUROPE: DIABETIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 92
TABLE 33 ASIA PACIFIC: DIABETIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 92
7.3.2 RENAL FORMULAS 92
7.3.2.1 Rise in patient population for chronic kidney disease to contribute to market growth 92
TABLE 34 RENAL FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 93
TABLE 35 NORTH AMERICA: RENAL FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 93
TABLE 36 EUROPE: RENAL FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 93
TABLE 37 ASIA PACIFIC: RENAL FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 94
7.3.3 HEPATIC FORMULAS 94
7.3.3.1 Rise in obesity and alcohol consumption drive demand for hepatic formulas 94
TABLE 38 HEPATIC FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 95
TABLE 39 NORTH AMERICA: HEPATIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 95
TABLE 40 EUROPE: HEPATIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 95
TABLE 41 ASIA PACIFIC: HEPATIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 96
7.3.4 PULMONARY FORMULAS 96
7.3.4.1 Rising disease prevalence to drive demand growth 96
TABLE 42 PULMONARY FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 96
TABLE 43 NORTH AMERICA: PULMONARY FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 97
TABLE 44 EUROPE: PULMONARY FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 97
TABLE 45 ASIA PACIFIC: PULMONARY FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 97
7.3.5 OTHER DISEASE-SPECIFIC FORMULAS 98
TABLE 46 OTHER DISEASE-SPECIFIC FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 98
TABLE 47 NORTH AMERICA: OTHER DISEASE-SPECIFIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 98
TABLE 48 EUROPE: OTHER DISEASE-SPECIFIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 99
TABLE 49 ASIA PACIFIC: OTHER DISEASE-SPECIFIC FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 99
7.4 PEPTIDE-BASED FORMULAS 99
7.4.1 BENEFITS OF PEPTIDE-BASED FORMULAS OVER OTHER SEGMENTS POSITIVELY IMPACTING MARKET GROWTH 99
TABLE 50 PEPTIDE-BASED ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 100
TABLE 51 NORTH AMERICA: PEPTIDE-BASED ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 100
TABLE 52 EUROPE: PEPTIDE-BASED ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 101
TABLE 53 ASIA PACIFIC: PEPTIDE-BASED ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 101
7.5 OTHER FORMULAS 101
TABLE 54 OTHER ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 102
TABLE 55 NORTH AMERICA: OTHER ENTERAL FEEDING FORMULAS MARKET, 2020-2027 (USD MILLION) 102
TABLE 56 EUROPE: OTHER ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 102
TABLE 57 ASIA PACIFIC: OTHER ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 103
8 ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 58 ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
8.2 ONCOLOGY 105
8.2.1 GROWING INCIDENCE OF CANCER TO INCREASE MARKET SHARE 105
TABLE 59 NUMBER OF NEW CANCER PATIENTS IN AMERICA 106
TABLE 60 ENTERAL FEEDING FORMULAS MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION) 106
TABLE 61 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 106
TABLE 62 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 107
TABLE 63 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 107
8.3 GASTROENTEROLOGY 108
8.3.1 INCREASING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE ADOPTION OF ENTERAL FEEDING FORMULAS 108
TABLE 64 INDICATIVE LIST OF DIGESTIVE DISEASES & DISORDERS REQUIRING ENTERAL FEEDING 108
TABLE 65 ENTERAL FEEDING FORMULAS MARKET FOR GASTROENTEROLOGY, BY REGION, 2020-2027 (USD MILLION) 109
TABLE 66 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 109
TABLE 67 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 109
TABLE 68 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 110
8.4 NEUROLOGY 110
8.4.1 HIGH BURDEN OF NEUROLOGICAL DISORDERS TO FUEL DEMAND FOR CLINICAL NUTRITION THERAPIES 110
TABLE 69 ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGY, BY REGION, 2020-2027 (USD MILLION) 111
TABLE 70 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 111
TABLE 71 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 112
TABLE 72 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 112
8.5 DIABETES 112
8.5.1 USE OF ENTERAL FEEDING SYSTEMS IN DIABETICS HELPS PREVENT HYPERGLYCEMIA AND ASSOCIATED COMPLICATIONS 112
TABLE 73 ENTERAL FEEDING FORMULAS MARKET FOR DIABETES, BY REGION, 2020-2027 (USD MILLION) 113
TABLE 74 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR DIABETES, BY COUNTRY, 2020-2027 (USD MILLION) 113
TABLE 75 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR DIABETES, BY COUNTRY, 2020-2027 (USD MILLION) 114
TABLE 76 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR DIABETES, BY COUNTRY, 2020-2027 (USD MILLION) 114
8.6 OTHER APPLICATIONS 115
TABLE 77 ENTERAL FEEDING FORMULAS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION) 115
TABLE 78 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 116
TABLE 79 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 116
TABLE 80 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 116
9 ENTERAL FEEDING FORMULAS MARKET, BY END USER 117
9.1 INTRODUCTION 118
TABLE 81 ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 (USD MILLION) 118
9.2 HOSPITALS 118
9.2.1 GROWING CHRONIC AND INFECTIOUS DISEASE PREVALENCE DRIVES MARKET GROWTH 118
TABLE 82 ENTERAL FEEDING FORMULAS MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 119
TABLE 83 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION) 119
TABLE 84 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION) 119
TABLE 85 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION) 120
9.3 LONG-TERM CARE FACILITIES 120
TABLE 86 ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 121
TABLE 87 ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2020-2027 (USD MILLION) 121
TABLE 88 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 121
TABLE 89 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 122
TABLE 90 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 122
9.3.1 NURSING HOMES 122
9.3.1.1 Need for nursing care in above-65 age group to drive market growth 122
TABLE 91 ENTERAL FEEDING FORMULAS MARKET FOR NURSING HOMES, BY REGION, 2020-2027 (USD MILLION) 123
TABLE 92 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR NURSING HOMES, BY COUNTRY, 2020-2027 (USD MILLION) 123
TABLE 93 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR NURSING HOMES, BY COUNTRY, 2020-2027 (USD MILLION) 124
TABLE 94 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR NURSING HOMES, BY COUNTRY, 2020-2027 (USD MILLION) 124
9.3.2 ASSISTED LIVING FACILITIES 124
9.3.2.1 Growth in chronic disease prevalence to support market growth 124
TABLE 95 ENTERAL FEEDING FORMULAS MARKET FOR ASSISTED LIVING FACILITIES, BY REGION, 2020-2027 (USD MILLION) 125
TABLE 96 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 125
TABLE 97 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 125
TABLE 98 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION) 126
9.3.3 HOME CARE AGENCIES & HOSPICES 126
9.3.3.1 Limitations associated with home care to hamper market growth 126
TABLE 99 ENTERAL FEEDING FORMULAS MARKET FOR HOME CARE AGENCIES & HOSPICES, BY REGION, 2020-2027 (USD MILLION) 126
TABLE 100 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR HOME CARE AGENCIES & HOSPICES, BY COUNTRY, 2020-2027 (USD MILLION) 127
TABLE 101 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR HOME CARE AGENCIES & HOSPICES, BY COUNTRY, 2020-2027 (USD MILLION) 127
TABLE 102 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR HOME CARE AGENCIES & HOSPICES, BY COUNTRY, 2020-2027 (USD MILLION) 127
10 ENTERAL FEEDING FORMULAS MARKET, BY REGION 128
10.1 INTRODUCTION 129
TABLE 103 ENTERAL FEEDING FORMULAS MARKET, BY REGION, 2020-2027 (USD MILLION) 129
10.2 NORTH AMERICA 129
FIGURE 32 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2021 130
TABLE 104 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 131
TABLE 105 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 131
TABLE 106 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 131
TABLE 107 NORTH AMERICA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 132
TABLE 108 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 132
TABLE 109 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 132
TABLE 110 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 133
10.2.1 US 133
10.2.1.1 Advanced healthcare system and availability of reimbursement for enteral nutrition to increase market growth 133
TABLE 111 US: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 134
TABLE 112 US: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 134
TABLE 113 US: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 135
TABLE 114 US: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 135
TABLE 115 US: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 136
TABLE 116 US: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 136
10.2.2 CANADA 136
10.2.2.1 Increasing incidence of chronic diseases such as diabetes and cancer supports market growth 136
TABLE 117 CANADA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 137
TABLE 118 CANADA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 137
TABLE 119 CANADA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 138
TABLE 120 CANADA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 138
TABLE 121 CANADA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 138
TABLE 122 CANADA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 139
10.3 EUROPE 139
TABLE 123 EUROPE: ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 140
TABLE 124 EUROPE: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 140
TABLE 125 EUROPE: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 140
TABLE 126 EUROPE: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 141
TABLE 127 EUROPE: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 141
TABLE 128 EUROPE: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 141
TABLE 129 EUROPE: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 142
10.3.1 UK 142
10.3.1.1 High incidence of target diseases to drive UK enteral feeding formulas market 142
TABLE 130 MACROINDICATORS FOR ENTERAL FEEDING FORMULAS MARKET IN UK 143
TABLE 131 UK: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 143
TABLE 132 UK: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 143
TABLE 133 UK: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 144
TABLE 134 UK: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 144
TABLE 135 UK: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 144
TABLE 136 UK: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 145
10.3.2 GERMANY 145
10.3.2.1 Germany to overtake UK and dominate European market by 2027 145
TABLE 137 MACROINDICATORS FOR ENTERAL FEEDING FORMULAS MARKET IN GERMANY 146
TABLE 138 GERMANY: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 146
TABLE 139 GERMANY: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 146
TABLE 140 GERMANY: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 147
TABLE 141 GERMANY: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 147
TABLE 142 GERMANY: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 147
TABLE 143 GERMANY: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 148
10.3.3 FRANCE 148
10.3.3.1 Well-established healthcare system and strong government support contribute to market growth 148
TABLE 144 MACROINDICATORS FOR ENTERAL FEEDING FORMULAS MARKET IN FRANCE 148
TABLE 145 FRANCE: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 149
TABLE 146 FRANCE: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 149
TABLE 147 FRANCE: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 149
TABLE 148 FRANCE: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 150
TABLE 149 FRANCE: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 150
TABLE 150 FRANCE: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 150
10.3.4 ITALY 151
10.3.4.1 Market growth attributed to growing geriatric population and need for nursing homes in Italy 151
TABLE 151 MACROINDICATORS FOR ENTERAL FEEDING FORMULAS MARKET IN ITALY 151
TABLE 152 ITALY: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 151
TABLE 153 ITALY: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 152
TABLE 154 ITALY: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 152
TABLE 155 ITALY: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 152
TABLE 156 ITALY: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 153
TABLE 157 ITALY: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 153
10.3.5 SPAIN 153
10.3.5.1 Significant increase in patients opting for enteral nutrition to support market growth 153
TABLE 158 SPAIN: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 154
TABLE 159 SPAIN: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 154
TABLE 160 SPAIN: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 155
TABLE 161 SPAIN: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 155
TABLE 162 SPAIN: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 155
TABLE 163 SPAIN: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 156
10.3.6 REST OF EUROPE 156
TABLE 164 ROE: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 157
TABLE 165 ROE: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 157
TABLE 166 ROE: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 157
TABLE 167 ROE: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 158
TABLE 168 ROE: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 158
TABLE 169 ROE: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 158
10.4 ASIA PACIFIC 159
FIGURE 33 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET SNAPSHOT 160
TABLE 170 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 161
TABLE 171 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 161
TABLE 172 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 161
TABLE 173 ASIA PACIFIC: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 174 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 162
TABLE 175 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 162
TABLE 176 ASIA PACIFIC: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 163
10.4.1 JAPAN 163
10.4.1.1 Rising geriatric population to drive market growth in Japan 163
TABLE 177 JAPAN: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 163
TABLE 178 JAPAN: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 164
TABLE 179 JAPAN: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 164
TABLE 180 JAPAN: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 165
TABLE 181 JAPAN: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 165
TABLE 182 JAPAN: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 165
10.4.2 CHINA 166
10.4.2.1 Growing investment in healthcare infrastructure development to drive adoption of enteral feeding formulas 166
TABLE 183 CHINA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 166
TABLE 184 CHINA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 167
TABLE 185 CHINA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 186 CHINA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 168
TABLE 187 CHINA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 168
TABLE 188 CHINA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 168
10.4.3 INDIA 169
10.4.3.1 Increasing incidence of preterm births and cancer cases to drive market growth in India 169
TABLE 189 INDIA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 170
TABLE 190 INDIA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 170
TABLE 191 INDIA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 170
TABLE 192 INDIA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 171
TABLE 193 INDIA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 171
TABLE 194 INDIA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 171
10.4.4 REST OF ASIA PACIFIC 172
TABLE 195 ROAPAC: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 172
TABLE 196 ROAPAC: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 173
TABLE 197 ROAPAC: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 198 ROAPAC: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 173
TABLE 199 ROAPAC: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 174
TABLE 200 ROAPAC: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 174
10.5 LATIN AMERICA 174
10.5.1 ECONOMIC DEVELOPMENT, INCREASING HEALTHCARE ACCESS, AND GROWING DISEASE PREVALENCE TO DRIVE MARKET GROWTH 174
TABLE 201 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 175
TABLE 202 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 176
TABLE 203 LATIN AMERICA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 176
TABLE 204 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 177
TABLE 205 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 177
TABLE 206 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 177
10.6 MIDDLE EAST & AFRICA 178
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND HEALTH INSURANCE PENETRATION TO SUPPORT MARKET GROWTH 178
TABLE 207 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET, BY STAGE, 2020-2027 (USD MILLION) 178
TABLE 208 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 179
TABLE 209 MIDDLE EAST AND AFRICA: DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE, 2020-2027 (USD MILLION) 179
TABLE 210 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 180
TABLE 211 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET, BY END USER, 2020-2027 USD MILLION) 180
TABLE 212 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION) 180
11 COMPETITIVE LANDSCAPE 181
11.1 OVERVIEW 181
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 181
FIGURE 34 KEY PLAYER STRATEGIES IN ENTERAL FEEDING FORMULAS MARKET, 2019-2022 181
11.3 MARKET SHARE ANALYSIS 182
FIGURE 35 ENTERAL FEEDING FORMULAS MARKET: MARKET SHARE ANALYSIS, 2021 (TOP FIVE PLAYERS) 182
TABLE 213 ENTERAL FEEDING FORMULAS MARKET: DEGREE OF COMPETITION 182
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 184
FIGURE 36 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ENTERAL FEEDING FORMULAS MARKET 184
11.5 COMPANY EVALUATION QUADRANT 185
11.5.1 STARS 185
11.5.2 EMERGING LEADERS 185
11.5.3 PERVASIVE PLAYERS 185
11.5.4 PARTICIPANTS 185
FIGURE 37 ENTERAL FEEDING FORMULAS MARKET: COMPANY EVALUATION QUADRANT, 2021 186
11.6 COMPETITIVE BENCHMARKING 187
11.6.1 COMPANY FOOTPRINT ANALYSIS 187
FIGURE 38 COMPANY FOOTPRINT ANALYSIS 187
11.6.2 COMPANY PRODUCT FOOTPRINT 188
TABLE 214 PRODUCT PORTFOLIO ANALYSIS 188
11.6.3 COMPANY REGIONAL FOOTPRINT 189
TABLE 215 REGIONAL REVENUE MIX 189
11.6.3.1 COMPETITIVE BENCHMARKING 190
TABLE 216 ENTERAL FEEDING FORMULAS MARKET: DETAILED LIST OF KEY START-UPS/SMES 190
TABLE 217 ENTERAL FEEDING FORMULAS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 191
11.7 COMPETITIVE SCENARIO AND TRENDS 191
TABLE 218 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-JULY 2022 191
TABLE 219 DEALS, JANUARY 2019-JULY 2022 192
TABLE 220 OTHER DEVELOPMENTS, JANUARY 2019-JULY 2022 192
12 COMPANY PROFILES 193
12.1 KEY PLAYERS 193
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ABBOTT 193
TABLE 221 ABBOTT: BUSINESS OVERVIEW 193
FIGURE 39 ABBOTT: COMPANY SNAPSHOT (2021) 194
12.1.2 NESTLE 197
TABLE 222 NESTLE: BUSINESS OVERVIEW 197
FIGURE 40 NESTLE: COMPANY SNAPSHOT (2021) 198
12.1.3 DANONE S.A. 201
TABLE 223 DANONE: BUSINESS OVERVIEW 201
FIGURE 41 DANONE: COMPANY SNAPSHOT (2021) 202
12.1.4 FRESENIUS KABI 205
TABLE 224 FRESENIUS KABI: BUSINESS OVERVIEW 205
FIGURE 42 FRESENIUS KABI: COMPANY SNAPSHOT (2021) 206
12.1.5 B. BRAUN MELSUNGEN AG 209
TABLE 225 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 209
FIGURE 43 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021) 210
12.1.6 OTSUKA HOLDINGS CO., LTD. 212
TABLE 226 OTSUKA HOLDINGS CO., LTD.: BUSINESS OVERVIEW 212
FIGURE 44 OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT (2021) 213
12.1.7 NUTRITIONAL MEDICINALS, LLC 214
TABLE 227 NUTRITIONAL MEDICINALS, LLC: BUSINESS OVERVIEW 214
12.1.8 KATE FARMS 215
TABLE 228 KATE FARMS: BUSINESS OVERVIEW 215
12.1.9 MEDTRITION INC. 216
TABLE 229 MEDTRITION INC.: BUSINESS OVERVIEW 216
12.1.10 VICTUS, INC. 217
TABLE 230 VICTUS, INC.: BUSINESS OVERVIEW 217
12.1.11 GLOBAL HEALTH PRODUCTS, INC. 218
TABLE 231 GLOBAL HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW 218
12.1.12 MEIJI HOLDINGS 219
TABLE 232 MEIJI HOLDINGS CO., LTD.: BUSINESS OVERVIEW 219
FIGURE 45 MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT (2021) 219
12.1.13 RECKITT BENCKISER GROUP 221
TABLE 233 RECKITT BENCKISER GROUP: BUSINESS OVERVIEW 221
FIGURE 46 RECKITT BENCKISER GROUP: COMPANY SNAPSHOT (2021) 222
12.2 OTHER COMPANIES 223
12.2.1 HORMEL FOODS CORPORATION 223
12.2.2 DERMARITE INDUSTRIES 223
12.2.3 MEDLINE INDUSTRIES, LP 224
12.2.4 REAL FOOD BLENDS 224
12.2.5 AJINOMOTO CAMBROOKE, INC. 225
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 226
13.1 DISCUSSION GUIDE 226
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 230
13.3 AVAILABLE CUSTOMIZATION OPTIONS 232
13.4 RELATED REPORTS 232
13.5 AUTHOR DETAILS 233
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security